World Health Organization (2024). WHO adds LC16m8 mpox vaccine to Emergency Use Listing. WHO. https://www.who.int/news/item/19-11-2024-who-adds-lc16m8-mpox-vaccine-to-emergency-use-listing

World Health Organization. (2024). Vaccine doses allocated to 9 African countries hardest hit by mpox surge. WHO.https://www.who.int/news/item/06-11-2024-vaccine-doses-allocated-to-9-african-countries-hardest-hit-by-mpox-surge

World Health Organization. (2024). Multi-country outbreak of mpox External Situation Report 32, published 30 April 2024 Data as received by WHO from national authorities as of 30 March 2024 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20240430_mpox_external-sitrep_32.pdf

Acharya, A., Kumar, N., Singh, K., & Byrareddy, S. N. (2024). Mpox in MSM: Tackling Stigma, Minimizing Risk Factors, Exploring Pathogenesis, and Treatment Approaches. Biomedical Journal, 100746. https://doi.org/10.1016/j.bj.2024.100746

Banik, A., Umpo, M., & Sinha, S. (n.d.). Monkeypox: A Global Challenge-An Overview.

Bashwira, M.-R., Mihigo, I. M., & Duclos, D. (2024). Key Considerations: Mpox, Mining, and Vulnerabilities of Women and Children in eastern DRC.https://www.researchgate.net/profile/Ashmita-Banik-2/publication/385280478

Braimah, J. A., Achore, M., Dery, F., Ayanore, M. A., Bisung, E., & Kuuire, V. (2024). Do self-rated health and previous vaccine uptake influence the willingness to accept MPOX vaccine during a public health emergency of concern? A cross-sectional study. PLOS Global Public Health, 4(8), e0003564. https://doi.org/10.1371/journal.pgph.0003564

Delight, E. A., Brunn, A. A., Ruiz, F., Gerard, J., Falconer, J., Liu, Y., Bah, B., Bett, B., Uzochukwu, B., & Oloko, O. K. (2024). Gaps and Opportunities for Data Systems and Economics to Support Priority Setting for Climate-Sensitive Infectious Diseases in Sub-Saharan Africa: A Rapid Scoping Review. medRxiv, 2024–09. https://www.medrxiv.org/content/10.1101/2024.09.20.24314043v1.full.pdf

Gashema, P., Musafiri, T., Ndahimana, F., Iradukunda, H., Saramba, E., Nyakatswau, S. T., Gahamanyi, N., Iradukunda, P. G., Ahmed, A., & Dzinamarira, T. (2024). Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses. Viruses, 16(10), 1578. https://doi.org/10.3390/v16101578

Hammershaimb, E. A., & Campbell, J. D. (2024). Vaccine Development. Pediatric Clinics, 71(3), 529–549. https://www.pediatric.theclinics.com/action/showPdf?pii=S0031-3955%2824%2900029-4

Lawrence, A. (2024). Assessing Vaccine Intentions, Knowledge, Self-Efficacy, and Trust: A Cross-Sectional Study on Perceptions of Monkeypox Vaccination and Public Health Risk Awareness in Makurdi, Benue State, Nigeria. Cureus, 16(10), e72131. doi: 10.7759/cureus.72131

León-Figueroa DA, Barboza JJ, Siddiq A, Sah R, Valladares-Garrido MJ, Rodriguez-Morales AJ (2024) Knowledge and attitude towards mpox: Systematic review and meta-analysis. PLoS ONE 19(8): e0308478. https://doi.org/10.1371/journal.pone.0308478

Manirambona, E., Khan, S. H., Siddiq, A., Albakri, K., Salamah, H. M., Hassan, N. A. I. F., Musa, S. S., & Dhama, K. (2024). Intriguing insight into unanswered questions about Mpox: Exploring health policy implications and considerations. Health Research Policy and Systems, 22(1), 37. https://link.springer.com/content/pdf/10.1186/s12961-024-01123-9.pdf

Maniskas, S., Marty, M., & Truong, A. (2024). The Challenge of Mpox Diagnosis for the Colorectal Surgeon. World Journal of Colorectal Surgery, 13(4), 141–143.https://journals.lww.com/wjcs/fulltext/2024/13040/the_challenge_of_mpox_diagnosis_for_the_colorectal.7.aspx

Mektebi, A., Elsaid, M., Yadav, T., Abdallh, F., Assker, M., Siddiq, A., Sayad, R., Saifi, M., & Farahat, R. A. (2024). Mpox vaccine acceptance among healthcare workers: A systematic review and meta-analysis. BMC Public Health, 24(1), 4. https://link.springer.com/content/pdf/10.1186/s12889-023-17186-2.pdf

Musuka, G., Moyo, E., Tungwarara, N., Mhango, M., Pierre, G., Saramba, E., Iradukunda, P. G., & Dzinamarira, T. (2024). A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: Lessons learned and evolving practices. IJID Regions, 100402 https://doi.org/10.1016/j.ijregi.2024.100402.

Phiri, S., & Lusaka, Z. (n.d.). Mpox in Zambia: An Overview of Pathogenesis, Diagnosis, and Public Health Implications.

Pitcock, C. T., Van Sickels, N., & Romanelli, F. (2024). Advances in recognizing, treating, and preventing mpox infection. JAPhA Pharmacotherapy, 1(2). https://www.japhapharmacotherapy.org/article/S2949-9623(23)00004-9/pdf

Poy, D., & Tohidfar, M. (2024). Molecular Docking and Dynamic Simulation on Investigation and Introduction of some Secondary Metabolites of Medicinal Plants with Antiviral Activity and Effective Vitamins for the Treatment of MPox. Journal of Applied Biotechnology Reports, 11(2), 1289–1300. https://www.biotechrep.ir/article_200161_6a8515aeac4ae73b415b1b4cda97eaa1.pdf

Shankar, M., Hartner, A.-M., Arnold, C. R., Gayawan, E., Kang, H., Kim, J.-H., Gilani, G. N., Cori, A., Fu, H., & Jit, M. (2024). Mathematical modelling to inform outbreak response vaccination. arXiv Preprint arXiv:2410.13923. https://arxiv.org/pdf/2410.13923

Sinumvayo, J. P., Munezero, P. C., Tope, A. T., Adeyemo, R. O., Bale, M. I., Mutsaka-Makuvaza, M. J., Daba, T. M., Nyandwi, J. B., Nzungize, L., & Mutumwinka, D. (2024). Vaccination and vaccine-preventable diseases in Africa. Scientific African, e02199. https://doi.org/10.1016/j.sciaf.2024.e02199

Tambo, E., Noungoue Ngounou, P. J., Njobet, M. P., Tappa, N. T., Ngogang, J., Hunter, M., Shaw, S. Y., Rimoin, A. W., Placide, M., & Kindrachuk, J. (2024). Assessment of risk perception and determinants of mpox for strengthening community engagement in local populations in Cameroon. medRxiv, 2024–03. https://www.medrxiv.org/content/10.1101/2024.03.20.24304629v1

Yappalparvi, A., Khatib, M. N., Balaraman, A. K., Rekha, M. M., Kaur, M., Sharma, G. C., ... & Bushi, G. (2025). Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis. AIDS Research and Therapy, 22(1), 1-10. https://doi.org/10.1186/s12981-025-00726-8

Zhou, J., Ye, T., Yang, Y., Li, E., Zhang, K., Wang, Y., Chen, S., Hu, J., Zhang, K., Liu, F., Gong, R., Chuai, X., Wang, Z., & Chiu, S. (2024). Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Molecular therapy : the journal of the American Society of Gene Therapy, 32(6), 1779–1789. DOI: 10.1016/j.ymthe.2024.04.028

Persad, G., Leland, R. J., Ottersen, T., Richardson, H. S., Saenz, C., Schaefer, G. O., & Emanuel, E. J. (2023). Fair domestic allocation of monkeypox virus countermeasures. The Lancet. Public health, 8(5), e378–e382. DOI: 10.1016/S2468-2667(23)00061-0

Karim, A. M., Kwon, J. E., Karim, M. A., Iftikhar, H., Yasir, M., Ullah, I., & Kang, S. C. (2022). Comprehensive update on the monkeypox outbreak. Frontiers in microbiology, 13, 1037583.  DOI: 10.3389/fmicb.2022.1037583

Bloch, E. M., Sullivan, D. J., Shoham, S., Tobian, A. A. R., Casadevall, A., & Gebo, K. A. (2022). The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. mBio, 13(6), e0286222.  DOI: 10.1128/mbio.02862-22

Li, Y., Lv, S., Zeng, Y., Chen, Z., Xia, F., Zhang, H., Dan, D., Hu, C., Tang, Y., Yang, Q., Ji, Y., Lu, J., & Wang, Z. (2024). Evaluation of Stability, Inactivation, and Disinfection Effectiveness of Mpox Virus. Viruses, 16(1), 104. DOI: 10.3390/v16010104

Paparini, S., Whelan, I., Mwendera, C., Hayes, R., Maatouk, I., Lewis, R., Prochazka Nunez, M., Mozalevskis, A., Wi, T., & Orkin, C. (2024). Prevention of sexual transmission of mpox: a systematic review and qualitative evidence synthesis of approaches. Infectious diseases (London, England), 56(8), 589–605. DOI: 10.1080/23744235.2024.2364801

Martinez, G. S., Dutt, M., Kelvin, D. J., & Kumar, A. (2024). PoxiPred: An Artificial-Intelligence-Based Method for the Prediction of Potential Antigens and Epitopes to Accelerate Vaccine Development Efforts against Poxviruses. Biology, 13(2), 125. DOI: 10.3390/biology13020125

Biesty, C. P., Hemingway, C., Woolgar, J., Taylor, K., Lawton, M. D., Waheed, M. W., Holford, D., & Taegtmeyer, M. (2024). Community led health promotion to counter stigma and increase trust amongst priority populations: lessons from the 2022-2023 UK mpox outbreak. BMC public health, 24(1), 1638.  DOI: 10.1186/s12889-024-19176-4